Every milestone matters. Together, they shaped our journey.

Gate2Brain is celebrating its sixth anniversary, marking another milestone in a journey driven by science,…

Gate2Brain Selected for the EU Business Hub Mission at World Health Expo Osaka 2026

,
Gate2Brain has been selected to participate in the EU Business Hub Business Mission at World Health Expo…

Shilpa Biocare Invests in Gate2Brain to Advance G2B-002, an Innovative Brain Cancer Therapeutic Candidate

, , ,
Gate2Brain signs a strategic partnership with Shilpa Biocare, including a €7 million investment…

Gate2Brain Joins the EIC Women Leadership Programme

At Gate2Brain, we are pleased to share that our CEO, Meritxell Teixidó, has been selected to participate…

Mercedes Hurtado – Meet the Team

https://youtu.be/XD2W5vk-Nko

The future belongs to children: 3 startups that are changing their day to day

Three emerging companies promoted by Barcelona Activa offer a series of initiatives aimed at improving…

Gate2Brain’s CEO Highlighted Among 16 Women Entrepreneurs Shaping Future Technology

We are pleased to share that Meritxell Teixidó, CEO and co-founder of Gate2Brain, has been included…

Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025

, ,
Gate2Brain will be participating in the Barcelona Deep Tech Summit 2025, a meeting point for companies,…

Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery Solutions

,
Gate2Brain showcased its cutting-edge peptide-based technology at BioJapan 2025 in Yokohama, strengthening…

Our team grows with new incorporations and new challenges

As we return from the summer break, we want to celebrate three amazing professionals who, in the past…

Clàudia Resa – Meet the Team

, , ,
https://youtu.be/A95BWdHVZ1k

Gate2Brain turns 5!

,
Last week, we came together — team members, collaborators, advisors, funding and institutional partners…

Gate2Brain obtains FDA Orphan Drug Designation for G2B-002

, ,
US FDA grants Orphan Drug Designation for G2B-002 in 2025, underscoring U.S. regulatory support for…

Gate2Brain arrives at Alhambra Venture with technology that crosses the brain barrier

,
Ninety-eight percent of drugs designed to treat neurological diseases never reach the brain. The blood-brain…

UCAM LifeTech Summit Awards Gate2Brain for Its Impact

, ,
The third edition of the LifeTech Summit, organized by UCAM HiTech, the UCAM innovation and business…
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social